Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy

Thousands of cancer patients are currently in clinical trials evaluating antiangiogenic therapy in the neoadjuvant setting, which is the treatment of localized primary tumors prior to surgical intervention. The rationale is that shrinking a tumor will improve surgical outcomes and minimize growth of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EMBO Mol Med
Huvudupphovsmän: Ebos, John ML, Mastri, Michalis, Lee, Christina R, Tracz, Amanda, Hudson, John M, Attwood, Kristopher, Cruz-Munoz, William R, Jedeszko, Christopher, Burns, Peter, Kerbel, Robert S
Materialtyp: Artigo
Språk:Inglês
Publicerad: BlackWell Publishing Ltd 2014
Ämnen:
Research Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287975/
https://ncbi.nlm.nih.gov/pubmed/25361689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201403989
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk